[A new principle for the design of immunotherapeutic compounds of directed action. Physiologically active substances reversibly screened with target-recognizing macromolecules].
Alakhov
V Iu
VIu
Arzhakov
S A
SA
Vasilenko
O V
OV
Voloshchuk
S G
SG
Glazkova-Stepanenko
I S
IS
D001402:B-Lymphocytes / Q000187:drug effects; D015195:Drug Design; D004768:Enterotoxins / Q000494:pharmacology; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D000922:Immunotoxins / Q000494:pharmacology*; D008223:Lymphoma / Q000188:drug therapy; D013601:T-Lymphocytes / Q000187:drug effects
D004768:Enterotoxins; D007074:Immunoglobulin G; D000922:Immunotoxins; C026066:enterotoxin A, Staphylococcal
Novyĭ printsip sozdaniia immunoterapevticheskikh soedineniĭ napravlennogo deĭstviia. Fiziologicheski aktivnye veshchestva, obratimo ékranirovannye mishen'- uznaiushchimi makromolekulami.